Clinical Trial

Development of an Innovative Method to Extract Cord Blood Stem Cells With High Efficiency

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2026 (before its estimated April 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The present study has the purpose to develop an innovative method for obtaining HSCs with a high yield. HSCs extracted from UCB using the traditional method followed by several steps of centrifugation will be compared to the new method which exploit a new biocompatible liquid, capable to separate the HSCs without causing mechanical stress to cells. The potential of ozone treatment to stimulate cells proliferation will be also assessed. Since ozone has been identified as an adjuvant to sustain cytoprotective pathways increasing cell performance, HSCs obtained from UCB samples will be treated by flowing ozone at low concentrations (between 2 and 20 μg/mL) in a mixture 1:1 with oxygen.
Trial Details
NCT Number NCT07468201
Lead Sponsor Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions HSCs Extraction
Enrollment 12 participants
Start Date 2024-04-10
Primary Completion 2026-04-10 (estimated)
Study Completion 2026-04-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-12